# EDGAR Filing Document

**Accession Number:** 0001757073
**File Stem:** 0001757073-25-000053
**Filing Date:** 2025-10
**Character Count:** 13591
**Document Hash:** e7a426c416048a7cc99b5a552ad5c3cc
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001757073-25-000053.hdr.sgml**: 20251029

**ACCESSION NUMBER**: 0001757073-25-000053

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20251029

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251029

**DATE AS OF CHANGE**: 20251029

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Envista Holdings Corp
- **CENTRAL INDEX KEY:** 0001757073
- **STANDARD INDUSTRIAL CLASSIFICATION:** DENTAL EQUIPMENT & SUPPLIES [3843]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 832206728
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39054
- **FILM NUMBER:** 251430231

**BUSINESS ADDRESS:**
- **STREET 1:** 200 S. KRAEMER BLVD., BLDG. E
- **CITY:** BREA
- **STATE:** CA
- **ZIP:** 92821
- **BUSINESS PHONE:** 714-817-5418

**MAIL ADDRESS:**
- **STREET 1:** 200 S. KRAEMER BLVD., BLDG. E
- **CITY:** BREA
- **STATE:** CA
- **ZIP:** 92821

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DH Dental Holding Corp.
- **DATE OF NAME CHANGE:** 20181025

?xml version='1.0' encoding='ASCII'? nvst-20251029

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

_____________________________________________

**FORM 8-K**

_____________________________________________

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of report (Date of earliest event reported): October 29, 2025**

_____________________________________________

![envistalogoa26.jpg](nvst-20251029_g1.jpg)

**ENVISTA HOLDINGS CORPORATION**

**(Exact Name of Registrant as Specified in Its Charter)**

_____________________________________________

**Delaware**

**(State or Other Jurisdiction of Incorporation)**

---

| | |
|:---|:---|
| **001-39054** | **83-2206728** |
| **(Commission File Number)** | **(IRS Employer Identification No.)** |

---

---

| | | |
|:---|:---|:---|
| **200 S. Kraemer Blvd., Building E** | **200 S. Kraemer Blvd., Building E** | **92821** |
| **Brea,** | **California** | **92821** |
| **(Address of Principal Executive Offices)** | **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**(714) 817-7000**

**(Registrant's Telephone Number, Including Area Code)**

**Not applicable**

**(Former Name or Former Address, if Changed Since Last Report)**

_____________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 <br> ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 <br> ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 <br> ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 <br> ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

------

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Common stock, $0.01 par value | NVST | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company&nbsp;&nbsp;&nbsp;&nbsp; ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**ITEM 7.01 REGULATION FD**

On October 29, 2025, Envista Holdings Corporation (the "Company") issued a press release announcing the release of its Sustainability Report (the "Report") highlighting the Company's actions and progress across environmental, social, and governance topics. The Report can be accessed on the Company's website at www.envistaco.com. A copy of the release is furnished herewith as Exhibit 99.1 and incorporated by reference herein.

The information included or incorporated by reference in this Item 7.01 is being furnished to the SEC and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

**ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| <u>[99.1](nvst-esgpressrelease102925.htm)</u> | <u>[Press Release dated October 29, 2025](nvst-esgpressrelease102925.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | ENVISTA HOLDINGS CORPORATION | ENVISTA HOLDINGS CORPORATION |
| Date: October 29, 2025 | By: | /s/ Mark Nance |
|  |  | Mark Nance |
|  |  | Senior Vice President, General Counsel and Secretary |

---

## Exhibit 99.1

**Envista Announces Release of 2024 Sustainability Report** 

BREA, Calif., October 29, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced the release of its 2024 Sustainability Report, highlighting ongoing efforts to pursue progress with purpose as it integrates sustainable and responsible business practices to achieve its mission of partnering with professionals to improve lives. The full report can be found on Envista's website.

"As a trusted partner to dental professionals worldwide, our commitment extends beyond delivering innovative products to how we lead and the positive impact we create. Our 2024 Sustainability Report showcases the meaningful initiatives Envista has undertaken throughout the past year across key focus areas like expanding access to high-quality dental care, supporting our colleagues and communities, being good stewards of the environment, and building on our very strong ethical foundation" said Paul Keel, Envista's CEO. "We're proud to share this update on our sustainability efforts and progress over the past year."

**Selected Highlights from Envista's 2024 Sustainability Report:** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Donated $1.9 million in goods and services to increase access to oral care health and education for underserved communities through the Envista Smile Project

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Completed inaugural Scope 3 GHG emissions inventory to better manage Envista's environmental footprint

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reduced our safety incident rate by 13%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Saw strong participation rates and engagement scores as part of Envista's employee engagement framework

Mr. Keel continued, "This year's achievements required the collective efforts of our teams across the organization and reflect our dedication to creating lasting value for all our stakeholders. We are pleased with our progress in 2024 and are further energized by the opportunity to deepen our positive impacts in the years ahead."

The 2024 Sustainability Report provides both Envista's sustainability-related performance to date and the foundation upon which Envista will continue to identify opportunities for continuous improvement across the Company's key sustainability topics. The Company welcomes all stakeholder feedback on its 2024 Sustainability Report, which can be shared via email at sustainability@envistaco.com.

------

**ABOUT ENVISTA** 

Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Our comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.

**FORWARD-LOOKING STATEMENTS**

Certain statements in this press release are "forward-looking" statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other things, the conditions in the U.S. and global economy, the impact of inflation and increasing interest rates, slower economic growth or recession, international economic, political, legal, compliance and business factors, the markets served by us and the financial markets, the impact of our debt obligations on our operations and liquidity, developments and uncertainties in trade policies and regulations including tariffs or other impositions on imported goods, contractions or growth rates and cyclicality of markets we serve, risks relating to product manufacturing, commodity costs and surcharges, our ability to adjust purchases and manufacturing capacity to reflect market conditions, reliance on sole or limited sources of supply, disruptions relating to war, terrorism, climate change, widespread protests and civil unrest, man-made and natural disasters, public health issues and other events, security breaches or other disruptions of our information technology systems or violations of data privacy laws, security breaches or other disruptions affecting our external information technology contractors, vendors or other service providers, fluctuations in inventory of our distributors and customers, loss of a key distributor, our relationships with and the performance of our channel partners, competition, our ability to develop and successfully market new products and services, our ability to attract, develop and retain our key personnel, the potential for improper conduct by our employees, agents or business partners, our compliance with applicable laws and regulations (including regulations relating to medical devices and the health care industry), the results of our clinical trials and perceptions thereof, penalties associated with any off-label marketing of our products, modifications to our products that require new marketing clearances or authorizations, our ability to effectively address cost reductions and other changes in the health care industry, our ability to successfully identify and consummate appropriate acquisitions and strategic investments, our ability to integrate the businesses we acquire and achieve the anticipated benefits of such acquisitions, contingent liabilities relating to acquisitions, investments and divestitures, our ability to adequately protect our intellectual property, the impact of our restructuring activities on our ability to grow, risks relating to impairment charges for our goodwill and intangible assets, changes in accounting standards and subjective assumptions, estimates and judgment by management, currency exchange rates, changes in tax laws applicable to multinational companies, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, risks relating to product, service or software defects, the impact of regulation on demand for our products and services, and labor matters. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our Annual Report on Form 10-K for fiscal year 2024 and our Quarterly reports on Form 10-Q. These forward-looking statements speak only as of the date of this press release and except to the extent required by applicable law, we do not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

------

**CONTACT**

Lauren Meinhardt

Senior Director, Corporate Communications

Envista Holdings Corporation

200 S. Kraemer Blvd., Building E

Brea, CA 92821

Telephone: (562) 383-8194

<br>